{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:45:05Z","timestamp":1785869105678,"version":"3.56.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["315351; 266621; 321564; 333284"],"award-info":[{"award-number":["315351; 266621; 321564; 333284"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008413","name":"Instrumentariumin Tiedes\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["GM-104080"],"award-info":[{"award-number":["GM-104080"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\u03b1-Melanocyte-stimulating hormone (\u03b1-MSH) regulates diverse physiological functions by activating melanocortin receptors (MC-R). However, the role of \u03b1-MSH and its possible target receptors in the heart remain completely unknown. Here we investigate whether \u03b1-MSH could be involved in pathological cardiac remodeling. We found that \u03b1-MSH was highly expressed in the mouse heart with reduced ventricular levels after transverse aortic constriction (TAC). Administration of a stable \u03b1-MSH analog protected mice against TAC-induced cardiac hypertrophy and systolic dysfunction. In vitro experiments revealed that MC5-R in cardiomyocytes mediates the anti-hypertrophic signaling of \u03b1-MSH. Silencing of MC5-R in cardiomyocytes induced hypertrophy and fibrosis markers in vitro and aggravated TAC-induced cardiac hypertrophy and fibrosis in vivo. Conversely, pharmacological activation of MC5-R improved systolic function and reduced cardiac fibrosis in TAC-operated mice. In conclusion, \u03b1-MSH is expressed in the heart and protects against pathological cardiac remodeling by activating MC5-R in cardiomyocytes. These results suggest that analogs of naturally occurring \u03b1-MSH, that have been recently approved for clinical use and have agonistic activity at MC5-R, may be of benefit in treating heart failure.<\/jats:p>","DOI":"10.1038\/s44319-024-00109-6","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T15:03:20Z","timestamp":1709823800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["\u03b1-Melanocyte-stimulating hormone alleviates pathological cardiac remodeling via melanocortin 5 receptor"],"prefix":"10.1038","volume":"25","author":[{"given":"Anni","family":"Suominen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9352-4326","authenticated-orcid":false,"given":"Guillem","family":"Saldo Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2503-148X","authenticated-orcid":false,"given":"Saku","family":"Ruohonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0778-1113","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta","family":"Pohjolainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5076-8366","authenticated-orcid":false,"given":"Bishwa","family":"Ghimire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvi T","family":"Ruohonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Saukkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jani","family":"Ijas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2336-4221","authenticated-orcid":false,"given":"Sini","family":"Skarp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1122-4651","authenticated-orcid":false,"given":"Leena","family":"Kaikkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9504-2091","authenticated-orcid":false,"given":"Minying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9659-7360","authenticated-orcid":false,"given":"Sharon L","family":"Wardlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Ruskoaho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2702-6505","authenticated-orcid":false,"given":"Virpi","family":"Talman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriika","family":"Savontaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7194-9326","authenticated-orcid":false,"given":"Risto","family":"Kerkel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6916-8627","authenticated-orcid":false,"given":"Petteri","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"109_CR1","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1021\/jm00132a010","volume":"32","author":"F Al-Obeidi","year":"1989","unstructured":"Al-Obeidi F, Castrucci AM, Hadley ME, Hruby VJ (1989) Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. J Med Chem 32:2555\u20132561","journal-title":"J Med Chem"},{"key":"109_CR2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","volume":"63","author":"AP Ambrosy","year":"2014","unstructured":"Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CSP, Sato N, Shah AN et al (2014) The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 63:1123\u20131133","journal-title":"J Am Coll Cardiol"},{"key":"109_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1677\/jme.0.0120203","volume":"12","author":"P Barrett","year":"1994","unstructured":"Barrett P, MacDonald A, Helliwell R, Davidson G, Morgan P (1994) Cloning and expression of a new member of the melanocyte-stimulating hormone receptor family. J Mol Endocrinol 12:203\u2013213","journal-title":"J Mol Endocrinol"},{"key":"109_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0008-6363(96)88507-5","volume":"30","author":"GW Booz","year":"1995","unstructured":"Booz GW, Baker KM (1995) Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc Res 30:537\u2013543","journal-title":"Cardiovasc Res"},{"key":"109_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0008-6363(01)00448-5","volume":"53","author":"F Bouzegrhane","year":"2002","unstructured":"Bouzegrhane F, Thibault G (2002) Is angiotensin II a proliferative factor of cardiac fibroblasts? Cardiovasc Res 53:304\u2013312","journal-title":"Cardiovasc Res"},{"key":"109_CR7","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nmeth.2999","volume":"11","author":"PW Burridge","year":"2014","unstructured":"Burridge PW, Matsa E, Shukla P, Lin ZC, Churko JM, Ebert AD, Lan F, Diecke S, Huber B, Mordwinkin NM, Plews JR, Abilez OJ, Cui B, Gold JD, Wu JC (2014) Chemically defined generation of human cardiomyocytes. Nat Methods, 11:855\u201360","journal-title":"Nat Methods,"},{"key":"109_CR8","doi-asserted-by":"publisher","first-page":"T77","DOI":"10.1530\/JME-15-0323","volume":"56","author":"NX Cawley","year":"2016","unstructured":"Cawley NX, Li Z, Loh YP (2016) 60 YEARS OF POMC: biosynthesis, trafficking, and secretion of pro-opiomelanocortin-derived peptides. J Mol Endocrinol 56:T77\u201397","journal-title":"J Mol Endocrinol"},{"key":"109_CR9","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1006\/jmcc.2000.1215","volume":"32","author":"MM Chen","year":"2000","unstructured":"Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH (2000) CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 32:1805\u20131819","journal-title":"J Mol Cell Cardiol"},{"key":"109_CR10","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1210\/er.2006-0034","volume":"27","author":"RD Cone","year":"2006","unstructured":"Cone RD (2006) Studies on the physiological functions of the melanocortin system. Endocr Rev 27:736\u2013749","journal-title":"Endocr Rev"},{"key":"109_CR11","doi-asserted-by":"publisher","first-page":"8115","DOI":"10.1021\/ja101428m","volume":"132","author":"L Doedens","year":"2010","unstructured":"Doedens L, Opperer F, Cai M, Beck JG, Dedek M, Palmer E, Hruby VJ, Kessler H(2010) Multiple N-methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity: pharmacological and conformational studies J Am Chem Soc 132:8115\u20138128","journal-title":"J Am Chem Soc"},{"key":"109_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.yjmcc.2018.07.130","volume":"121","author":"LE Dorn","year":"2018","unstructured":"Dorn LE, Petrosino JM, Wright P, Accornero F (2018) CTGF\/CCN2 is an autocrine regulator of cardiac fibrosis. J Mol Cell Cardiol 121:205\u2013211","journal-title":"J Mol Cell Cardiol"},{"key":"109_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.molmet.2016.07.009","volume":"5","author":"PJ Enriori","year":"2016","unstructured":"Enriori PJ, Chen W, Garcia-Rudaz MC, Grayson BE, Evans AE, Comstock SM, Gebhardt U, M\u00fcller HL, Reinehr T, Henry BA, Brown RD, Bruce CR, Simonds SE, Litwak SA, Mcgee SL, Luquet S, Martinez S, Jastroch M, Tsch\u00f6p MH, Watt MJ, Clarke IJ, Roth CL, Grove KL, Cowley MA (2016) \u03b1-Melanocyte stimulating hormone promotes muscle glucose uptake via melanocortin 5 receptors. Mol Metab, 5:807\u2013822","journal-title":"Mol Metab,"},{"key":"109_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/BF00995160","volume":"20","author":"Z Fathi","year":"1995","unstructured":"Fathi Z, Iben LG, Parker EM (1995) Cloning, expression, and tissue distribution of a fifth melanocortin receptor subtype. Neurochem Res 20:107\u2013113","journal-title":"Neurochem Res"},{"key":"109_CR15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.stemcr.2014.09.002","volume":"3","author":"G F\u00f6ldes","year":"2014","unstructured":"F\u00f6ldes G, Matsa E, Kriston-Vizi J, Leja T, Amisten S, Kolker L, Kodagoda T, Dolatshad NF, Mioulane M, Vauchez K, Ar\u00e1nyi T, Ketteler R, Schneider MD, Denning C, Harding SE (2014) Aberrant \u03b1-adrenergic hypertrophic response in cardiomyocytes from human induced pluripotent cells. Stem Cell Reports, 3:905\u201314","journal-title":"Stem Cell Reports,"},{"key":"109_CR16","doi-asserted-by":"publisher","first-page":"H397","DOI":"10.1152\/ajpheart.00088.2013","volume":"305","author":"L Garcia-Menendez","year":"2013","unstructured":"Garcia-Menendez L, Karamanlidis G, Kolwicz S, Tian R (2013) Substrain specific response to cardiac pressure overload in C57BL\/6 mice. Am J Physiol Heart Circ Physiol 305:H397\u2013402","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"109_CR17","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1021\/jm000211e","volume":"43","author":"P Grieco","year":"2000","unstructured":"Grieco P, Balse PM, Weinberg D, MacNeil T, Hruby VJ (2000) D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity. J Med Chem 43:4998\u20135002","journal-title":"J Med Chem"},{"key":"109_CR18","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1021\/jm701181n","volume":"51","author":"P Grieco","year":"2008","unstructured":"Grieco P, Cai M, Liu L, Mayorov A, Chandler K, Trivedi D, Lin G, Campiglia P, Novellino E, Hruby VJ (2008) Design and microwave-assisted synthesis of novel macrocyclic peptides active at melanocortin receptors: discovery of potent and selective hMC5R receptor antagonists. J Med Chem 51:2701\u20132707","journal-title":"J Med Chem"},{"key":"109_CR19","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1006\/bbrc.2002.6739","volume":"292","author":"P Grieco","year":"2002","unstructured":"Grieco P, Han G, Weinberg D, Van der Ploeg LH, Hruby VJ (2002) Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6. Biochem Biophys Res Commun 292:1075\u20131080","journal-title":"Biochem Biophys Res Commun"},{"key":"109_CR20","doi-asserted-by":"publisher","first-page":"H253","DOI":"10.1152\/ajpheart.00786.2010","volume":"301","author":"ME Hall","year":"2011","unstructured":"Hall ME, Smith G, Hall JE, Stec DE (2011) Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice. Am J Physiol Heart Circ Physiol 301:H253\u2013260","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"109_CR21","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, Hoffman P, Stoeckius M, Papalexi E, Mimitou EP, Jain J, Srivastava A, Stuart T, Fleming LM, Yeung B, Rogers AJ, Mcelrath JM, Blish CA, Gottardo R, Smibert P, Satija R (2021) Integrated analysis of multimodal single-cell data. Cell 184:3573\u20133587.e29","journal-title":"Cell"},{"key":"109_CR22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbrc.2008.03.100","volume":"370","author":"N Hayata","year":"2008","unstructured":"Hayata N, Fujio Y, Yamamoto Y, Iwakura T, Obana M, Takai M, Mohri T, Nonen S, Maeda M, Azuma J (2008) Connective tissue growth factor induces cardiac hypertrophy through Akt signaling. Biochem Biophys Res Commun 370:274\u2013278","journal-title":"Biochem Biophys Res Commun"},{"key":"109_CR23","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1056\/NEJMra021498","volume":"348","author":"M Jessup","year":"2003","unstructured":"Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348:2007\u20132018","journal-title":"N Engl J Med"},{"key":"109_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.774013","volume":"12","author":"JJ Kadiri","year":"2021","unstructured":"Kadiri JJ, Tadayon S, Thapa K, Suominen A, Hollm\u00e9n M, Rinne P (2021) Melanocortin 1 receptor deficiency in hematopoietic cells promotes the expansion of inflammatory leukocytes in atherosclerotic mice. Front Immunol 12:774013","journal-title":"Front Immunol"},{"key":"109_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1124\/molpharm.120.000094","volume":"99","author":"ST Karhu","year":"2021","unstructured":"Karhu ST, Ruskoaho H, Talman V (2021) Distinct regulation of cardiac fibroblast proliferation and transdifferentiation by classical and novel protein kinase C isoforms: possible implications for new antifibrotic therapies. Mol Pharmacol 99:104\u2013113","journal-title":"Mol Pharmacol"},{"key":"109_CR26","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1007\/s00204-018-2257-1","volume":"92","author":"ST Karhu","year":"2018","unstructured":"Karhu ST, V\u00e4lim\u00e4ki MJ, Jumppanen M, Kinnunen SM, Pohjolainen L, Leigh RS, Auno S, F\u00f6ldes G, Boije AF, Genn\u00e4s G, Yli-Kauhaluoma J, Ruskoaho H, Talman V (2018.) Stem cells are the most sensitive screening tool to identify toxicity of GATA4-targeted novel small-molecule compounds. Arch Toxicol, 92:2897\u20132911","journal-title":"Arch Toxicol,"},{"key":"109_CR27","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1021\/bi00181a015","volume":"33","author":"O Labb\u00e9","year":"1994","unstructured":"Labb\u00e9 O, Desarnaud F, Eggerickx D, Vassart G, Parmentier M (1994) Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry 33:4543\u20134549","journal-title":"Biochemistry"},{"key":"109_CR28","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.1093\/emboj\/cdg474","volume":"22","author":"Q Liang","year":"2003","unstructured":"Liang Q, Bueno OF, Wilkins BJ, Kuan CY, Xia Y, Molkentin JD (2003) c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling. EMBO J 22:5079\u20135089","journal-title":"EMBO J"},{"key":"109_CR29","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.yjmcc.2003.10.001","volume":"35","author":"Q Liang","year":"2003","unstructured":"Liang Q, Molkentin JD (2003) Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. J Mol Cell Cardiol 35:1385\u20131394","journal-title":"J Mol Cell Cardiol"},{"key":"109_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.yjmcc.2021.12.011","volume":"165","author":"R Lin","year":"2022","unstructured":"Lin R, Rahtu-Korpela L, Szabo Z, Kemppi A, Skarp S, Kiviniemi AM, Lepoj\u00e4rvi ES, Halmetoja E, Kilpi\u00f6 T, Porvari K, Pakanen L, Tolva J, Paakkanen R, Segersv\u00e4rd H, Tikkanen I, Laine M, Sinisalo J, Lakkisto P, Huikuri H, Magga J, Junttila J, Kerkel\u00e4 R (2022) MiR-185-5p regulates the development of myocardial fibrosis. J Mol Cell Cardiol, 165:130\u2013140","journal-title":"J Mol Cell Cardiol,"},{"key":"109_CR31","doi-asserted-by":"publisher","first-page":"47642","DOI":"10.18632\/oncotarget.17465","volume":"8","author":"G Liu","year":"2017","unstructured":"Liu G, Li M, Saeed M, Xu Y, Ren Q, Sun C (2017) \u03b1MSH inhibits adipose inflammation via reducing FoxOs transcription and blocking Akt\/JNK pathway in mice. Oncotarget 8:47642\u201347654","journal-title":"Oncotarget"},{"key":"109_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/mol.104.000497","volume":"66","author":"G Milligan","year":"2004","unstructured":"Milligan G (2004) G protein-coupled receptor dimerization: function and ligand pharmacology. Mol Pharmacol 66:1\u20137","journal-title":"Mol Pharmacol"},{"key":"109_CR33","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/0196-9781(93)90167-F","volume":"14","author":"WR Millington","year":"1993","unstructured":"Millington WR, Evans VR, Forman LJ, Battie CN (1993) Characterization of beta-endorphin- and alpha-MSH-related peptides in rat heart. Peptides. 14:1141\u20131147","journal-title":"Peptides."},{"key":"109_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0008-6363(99)00076-0","volume":"43","author":"WR Millington","year":"1999","unstructured":"Millington WR, Rosenthal DW, Unal CB, Nyquist-Battie C (1999) Localization of pro-opiomelanocortin mRNA transcripts and peptide immunoreactivity in rat heart. Cardiovasc Res 43:107\u2013116","journal-title":"Cardiovasc Res"},{"key":"109_CR35","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1073\/pnas.062453699","volume":"99","author":"T Minamino","year":"2002","unstructured":"Minamino T, Yujiri T, Terada N, Taffet GE, Michael LH, Johnson GL, Schneider MD (2002) MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq. Proc Natl Acad Sci USA 99:3866\u20133871","journal-title":"Proc Natl Acad Sci USA"},{"key":"109_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101603","volume":"59","author":"T Montero-Melendez","year":"2022","unstructured":"Montero-Melendez T, Boesen T, Jonassen TEN (2022) Translational advances of melanocortin drugs: Integrating biology, chemistry and genetics. Semin Immunol 59:101603","journal-title":"Semin Immunol"},{"key":"109_CR37","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1126\/science.1325670","volume":"257","author":"K Mountjoy","year":"1992","unstructured":"Mountjoy K, Robbins L, Mortrud M, Cone R (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257:1248\u20131251","journal-title":"Science"},{"key":"109_CR38","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/278423a0","volume":"278","author":"S Nakanishi","year":"1979","unstructured":"Nakanishi S, Inoue A, Kita T, Nakamura M, Chang AC, Cohen SN, Numa S (1979) Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor. Nature 278:423\u2013427","journal-title":"Nature"},{"key":"109_CR39","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1128\/MCB.18.6.3518","volume":"18","author":"S Nemoto","year":"1998","unstructured":"Nemoto S, Sheng Z, Lin A (1998) Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol Cell Biol 18:3518\u20133526","journal-title":"Mol Cell Biol"},{"key":"109_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.553852","volume":"11","author":"L Pohjolainen","year":"2020","unstructured":"Pohjolainen L, Easton J, Solanki R, Ruskoaho H, Talman V (2020) Pharmacological protein kinase C modulators reveal a pro-hypertrophic role for novel protein kinase C isoforms in human induced pluripotent stem cell-derived cardiomyocytes. Front Pharmacol 11:553852","journal-title":"Front Pharmacol"},{"key":"109_CR41","doi-asserted-by":"publisher","first-page":"100020","DOI":"10.1016\/j.jmccpl.2022.100020","volume":"2","author":"L Pohjolainen","year":"2023","unstructured":"Pohjolainen L, Ruskoaho H, Talman V (2023) Transcriptomics reveal stretched human pluripotent stem cell-derived cardiomyocytes as an advantageous hypertrophy model. Journal of Molecular and Cellular Cardiology Plus 2:100020","journal-title":"Journal of Molecular and Cellular Cardiology Plus"},{"key":"109_CR42","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1161\/CIRCULATIONAHA.119.043053","volume":"141","author":"Z Ren","year":"2020","unstructured":"Ren Z, Yu P, Li D, Li Z, Liao Y, Wang Y, Zhou B, Wang L (2020) Single-cell reconstruction of progression trajectory reveals intervention principles in pathological cardiac hypertrophy. Circulation 141:1704\u20131719","journal-title":"Circulation"},{"key":"109_CR43","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/cvr\/cvs335","volume":"97","author":"P Rinne","year":"2013","unstructured":"Rinne P, Nordlund W, Heinonen I, Penttinen AM, Saraste A, Ruohonen ST, M\u00e4kel\u00e4 S, V\u00e4h\u00e4talo L, Kaipio K, Cai M, Hruby VJ, Ruohonen S, Savontaus E (2013) \u03b1-Melanocyte-stimulating hormone regulates vascular NO availability and protects against endothelial dysfunction. Cardiovasc Res, 97:360\u20138","journal-title":"Cardiovasc Res,"},{"key":"109_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1161\/CIRCULATIONAHA.116.025889","volume":"136","author":"P Rinne","year":"2017","unstructured":"Rinne P, Rami M, Nuutinen S, Santovito D, Van Der Vorst EPC, Guillamat-Prats R, Lyytik\u00e4inen LP, Raitoharju E, Oksala N, Ring L, Cai M, Hruby VJ, Lehtim\u00e4ki T, Weber C, Steffens S (2017) Melanocortin 1 Receptor Signaling Regulates Cholesterol Transport in Macrophages. Circulation 136:83\u201397","journal-title":"Circulation"},{"key":"109_CR45","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1161\/ATVBAHA.113.302963","volume":"34","author":"P Rinne","year":"2014","unstructured":"Rinne P, Silvola JM, Hellberg S, St\u00e5hle M, Liljenb\u00e4ck H, Salom\u00e4ki H, Koskinen E, Nuutinen S, Saukko P, Knuuti J, Saraste A, Roivainen A, Savontaus E (2014) Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice. Arterioscler Thromb Vasc Biol, 34:1346\u201354","journal-title":"Arterioscler Thromb Vasc Biol,"},{"key":"109_CR46","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00018-014-1800-3","volume":"72","author":"AR Rodrigues","year":"2015","unstructured":"Rodrigues AR, Almeida H, Gouveia AM (2015) Intracellular signaling mechanisms of the melanocortin receptors: current state of the art. Cell Mol Life Sci 72:1331\u20131345","journal-title":"Cell Mol Life Sci"},{"key":"109_CR47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1172\/JCI0214938","volume":"110","author":"J Sadoshima","year":"2002","unstructured":"Sadoshima J, Montagne O, Wang Q, Yang G, Warden J, Liu J, Takagi G, Karoor V, Hong C, Johnson GL, Vatner DE, Vatner SF (2002) The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. J Clin Invest, 110:271\u20139","journal-title":"J Clin Invest,"},{"key":"109_CR48","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0014-2999(96)00959-4","volume":"319","author":"HB Schi\u00f6th","year":"1997","unstructured":"Schi\u00f6th HB, Muceniece R, Larsson M, Mutulis F, Szardenings M, Prusis P, Lindeberg G, Wikberg JE (1997) Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. Eur J Pharmacol 319:369\u2013373","journal-title":"Eur J Pharmacol"},{"key":"109_CR49","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1021\/jm025539h","volume":"45","author":"IK Sebhat","year":"2002","unstructured":"Sebhat IK, Martin WJ, Ye Z, Barakat K, Mosley RT, Johnston DB, Bakshi R, Palucki B, Weinberg DH, Macneil T, Kalyani RN, Tang R, Stearns RA, Miller RR, Tamvakopoulos C, Strack AM, Mcgowan E, Cashen DE, Drisko JE, Hom GJ, Howard AD, Macintyre DE, Van Der Ploeg LH, Patchett AA, Nargund RP (2002) Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist. J Med Chem, 45:4589\u201393","journal-title":"J Med Chem,"},{"key":"109_CR50","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1210\/edrv-9-1-159","volume":"9","author":"AI Smith","year":"1988","unstructured":"Smith AI, Funder JW (1988) Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev 9:159\u2013179","journal-title":"Endocr Rev"},{"key":"109_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/hh1301.092687","volume":"89","author":"DS Sohal","year":"2001","unstructured":"Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, Penninger JM, Molkentin JD (2001) Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res 89:20\u201325","journal-title":"Circ Res"},{"key":"109_CR52","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1161\/HYPERTENSIONAHA.114.03279","volume":"63","author":"Z Szab\u00f3","year":"2014","unstructured":"Szab\u00f3 Z, Magga J, Alakoski T, Ulvila J, Piuhola J, Vainio L, Kivirikko KI, Vuolteenaho O, Ruskoaho H, Lipson KE, Signore P, Kerkel\u00e4 R (2014) Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure. Hypertension 63:1235\u201340","journal-title":"Hypertension"},{"key":"109_CR53","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","volume":"89","author":"YK Tham","year":"2015","unstructured":"Tham YK, Bernardo BC, Ooi JY, Weeks KL, McMullen JR (2015) Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch Toxicol 89:1401\u20131438","journal-title":"Arch Toxicol"},{"key":"109_CR54","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3389\/fphys.2018.01475","volume":"9","author":"MC Trotta","year":"2018","unstructured":"Trotta MC, Maisto R, Alessio N, Hermenean A, D\u2019Amico M, Di Filippo C (2018) The melanocortin MC5R as a new target for treatment of high glucose-induced hypertrophy of the cardiac H9c2 cells. Front Physiol 9:1475","journal-title":"Front Physiol"},{"key":"109_CR55","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Ferguson JF, Generoso G, Ho JE, Kalani R, Khan SS, Kissela BM, Knutson KL, Levine DA, Lewis TT, Liu J, Loop MS, Ma J, Mussolino ME, Navaneethan SD, Perak AM, Poudel R, Rezk-Hanna M, Roth GA, Schroeder EB, Shah SH, Thacker EL, Vanwagner LB, Virani SS, Voecks JH, Wang NY, Yaffe K, Martin SS (2022) Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation 145:e153\u2013e639","journal-title":"Circulation"},{"key":"109_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1172\/JCI62839","volume":"123","author":"JH Van Berlo","year":"2013","unstructured":"Van Berlo JH, Maillet M, Molkentin JD (2013) Signaling effectors underlying pathologic growth and remodeling of the heart. J Clin Invest 123:37\u201345","journal-title":"J Clin Invest"},{"key":"109_CR56","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1007\/s00018-020-03511-0","volume":"77","author":"Y Xu","year":"2020","unstructured":"Xu Y, Guan X, Zhou R, Gong R (2020) Melanocortin 5 receptor signaling pathway in health and disease. Cell Mol Life Sci 77:3831\u20133840","journal-title":"Cell Mol Life Sci"},{"key":"109_CR57","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2169\/internalmedicine.45.1546","volume":"45","author":"M Yamaoka-Tojo","year":"2006","unstructured":"Yamaoka-Tojo M, Tojo T, Shioi T, Masuda T, Inomata T, Izumi T (2006) Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure. Intern Med 45:429\u2013434","journal-title":"Intern Med"},{"key":"109_CR58","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejphar.2010.12.020","volume":"660","author":"Y Yang","year":"2011","unstructured":"Yang Y (2011) Structure, function and regulation of the melanocortin receptors. Eur J Pharmacol 660:125\u2013130","journal-title":"Eur J Pharmacol"},{"key":"109_CR59","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/01.RES.83.7.752","volume":"83","author":"M Yano","year":"1998","unstructured":"Yano M, Kim S, Izumi Y, Yamanaka S, Iwao H (1998) Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension. Circ Res 83:752\u2013760","journal-title":"Circ Res"},{"key":"109_CR60","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.yjmcc.2010.04.010","volume":"49","author":"PO Yoon","year":"2010","unstructured":"Yoon PO, Lee MA, Cha H, Jeong MH, Kim J, Jang SP, Choi BY, Jeong D, Yang DK, Hajjar RJ Park WJ (2010) The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis. J Mol Cell Cardiol 49:294\u2013303","journal-title":"J Mol Cell Cardiol"},{"key":"109_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.crphys.2019.10.001","volume":"1","author":"M Zi","year":"2019","unstructured":"Zi M, Stafford N, Prehar S, Baudoin F, Oceandy D, Wang X, Bui T, Shaheen M, Neyses L, Cartwright EJ (2019) Cardiac hypertrophy or failure?\u2014A systematic evaluation of the transverse aortic constriction model in C57BL\/6NTac and C57BL\/6J substrains. Curr Res Physiol 1:1\u201310","journal-title":"Curr Res Physiol"}],"container-title":["EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-024-00109-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44319-024-00109-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-024-00109-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:02:53Z","timestamp":1785866573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44319-024-00109-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,12]]}},"alternative-id":["109"],"URL":"https:\/\/doi.org\/10.1038\/s44319-024-00109-6","relation":{},"ISSN":["1469-3178"],"issn-type":[{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"19 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"21"}}